| 000 | 01357 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517075020.0 | ||
| 264 | 0 | _c20160204 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.2015.13969 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrey, Sorilla | |
| 245 | 0 | 0 |
_aSafety of Propranolol Therapy for Severe Infantile Hemangioma. _h[electronic resource] |
| 260 |
_bJAMA _cJan 2016 |
||
| 300 |
_a413-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCausality |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCompassionate Use Trials |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 |
_aHemangioma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOff-Label Use |
| 650 | 0 | 4 |
_aPropranolol _xadministration & dosage |
| 700 | 1 | _aVoisard, Jean-Jacques | |
| 700 | 1 | _aDelarue, Alain | |
| 700 | 1 | _aLebbe, Geneviève | |
| 700 | 1 | _aTaïeb, Alain | |
| 700 | 1 | _aLeaute-Labreze, Christine | |
| 700 | 1 | _aEzzedine, Khaled | |
| 773 | 0 |
_tJAMA _gvol. 315 _gno. 4 _gp. 413-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.2015.13969 _zAvailable from publisher's website |
| 999 |
_c25671465 _d25671465 |
||